Skip to main content
. Author manuscript; available in PMC: 2015 Feb 1.
Published in final edited form as: Pediatr Blood Cancer. 2013 Sep 4;61(2):245–252. doi: 10.1002/pbc.24724

Figure 2.

Figure 2

Quisinostat activity in vivo against individual solid tumor xenografts. Kaplan-Meier curves showing the probability for EFS (left), relative tumor volume (center), and individual tumor volumes (right) graphs are shown for selected xenografts (Rh28, D456, and D645). Controls (gray lines); Treated (black lines), significances of the difference between treated and control groups are included.